Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Dysferlin in membrane trafficking and patch repair.

Glover L, Brown RH Jr.

Traffic. 2007 Jul;8(7):785-94. Epub 2007 Jun 5. Review.

2.

Defective membrane repair in dysferlin-deficient muscular dystrophy.

Bansal D, Miyake K, Vogel SS, Groh S, Chen CC, Williamson R, McNeil PL, Campbell KP.

Nature. 2003 May 8;423(6936):168-72.

PMID:
12736685
3.

Dysferlin and the plasma membrane repair in muscular dystrophy.

Bansal D, Campbell KP.

Trends Cell Biol. 2004 Apr;14(4):206-13. Review.

PMID:
15066638
4.

Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency.

Ho M, Post CM, Donahue LR, Lidov HG, Bronson RT, Goolsby H, Watkins SC, Cox GA, Brown RH Jr.

Hum Mol Genet. 2004 Sep 15;13(18):1999-2010. Epub 2004 Jul 14.

PMID:
15254015
6.

Reduced plasma membrane expression of dysferlin mutants is attributed to accelerated endocytosis via a syntaxin-4-associated pathway.

Evesson FJ, Peat RA, Lek A, Brilot F, Lo HP, Dale RC, Parton RG, North KN, Cooper ST.

J Biol Chem. 2010 Sep 10;285(37):28529-39. doi: 10.1074/jbc.M110.111120. Epub 2010 Jul 1.

7.

Aberrant dysferlin trafficking in cells lacking caveolin or expressing dystrophy mutants of caveolin-3.

Hernández-Deviez DJ, Martin S, Laval SH, Lo HP, Cooper ST, North KN, Bushby K, Parton RG.

Hum Mol Genet. 2006 Jan 1;15(1):129-42. Epub 2005 Nov 30.

PMID:
16319126
8.

Patients with a non-dysferlin Miyoshi myopathy have a novel membrane repair defect.

Jaiswal JK, Marlow G, Summerill G, Mahjneh I, Mueller S, Hill M, Miyake K, Haase H, Anderson LV, Richard I, Kiuru-Enari S, McNeil PL, Simon SM, Bashir R.

Traffic. 2007 Jan;8(1):77-88. Epub 2006 Nov 21.

9.

The earliest pathologic alterations in dysferlinopathy.

Selcen D, Stilling G, Engel AG.

Neurology. 2001 Jun 12;56(11):1472-81.

PMID:
11402103
10.

Dysferlin is expressed in human placenta but does not associate with caveolin.

Vandré DD, Ackerman WE 4th, Kniss DA, Tewari AK, Mori M, Takizawa T, Robinson JM.

Biol Reprod. 2007 Sep;77(3):533-42. Epub 2007 Jun 6.

PMID:
17554076
11.

Muscle inflammation and MHC class I up-regulation in muscular dystrophy with lack of dysferlin: an immunopathological study.

Confalonieri P, Oliva L, Andreetta F, Lorenzoni R, Dassi P, Mariani E, Morandi L, Mora M, Cornelio F, Mantegazza R.

J Neuroimmunol. 2003 Sep;142(1-2):130-6.

PMID:
14512171
12.

Absence of dysferlin alters myogenin expression and delays human muscle differentiation "in vitro".

de Luna N, Gallardo E, Soriano M, Dominguez-Perles R, de la Torre C, Rojas-García R, García-Verdugo JM, Illa I.

J Biol Chem. 2006 Jun 23;281(25):17092-8. Epub 2006 Apr 11.

13.

Membrane repair defects in muscular dystrophy are linked to altered interaction between MG53, caveolin-3, and dysferlin.

Cai C, Weisleder N, Ko JK, Komazaki S, Sunada Y, Nishi M, Takeshima H, Ma J.

J Biol Chem. 2009 Jun 5;284(23):15894-902. doi: 10.1074/jbc.M109.009589. Epub 2009 Apr 20.

14.

Plasma membrane repair in plants.

Schapire AL, Valpuesta V, Botella MA.

Trends Plant Sci. 2009 Dec;14(12):645-52. doi: 10.1016/j.tplants.2009.09.004. Epub 2009 Oct 12. Review.

PMID:
19819752
15.

Proteomic identification of dysferlin-interacting protein complexes in human vascular endothelium.

Leung C, Utokaparch S, Sharma A, Yu C, Abraham T, Borchers C, Bernatchez P.

Biochem Biophys Res Commun. 2011 Nov 18;415(2):263-9. doi: 10.1016/j.bbrc.2011.10.031. Epub 2011 Oct 19.

PMID:
22037454
16.

[Dysferlin expression in limb-girdle muscular dystrophy and Miyoshi myopathy: analysis of 45 cases].

Ren SC, Yan CZ, Li MX, Liu SP, Wu JL, Zhao YY, Li W, Li DN.

Zhonghua Yi Xue Za Zhi. 2007 Jun 5;87(21):1486-90. Chinese.

PMID:
17785089
17.

DYC-1, a protein functionally linked to dystrophin in Caenorhabditis elegans is associated with the dense body, where it interacts with the muscle LIM domain protein ZYX-1.

Lecroisey C, Martin E, Mariol MC, Granger L, Schwab Y, Labouesse M, Ségalat L, Gieseler K.

Mol Biol Cell. 2008 Mar;19(3):785-96. Epub 2007 Dec 19.

18.

Mutation impact on dysferlin inferred from database analysis and computer-based structural predictions.

Therrien C, Dodig D, Karpati G, Sinnreich M.

J Neurol Sci. 2006 Dec 1;250(1-2):71-8. Epub 2006 Sep 22.

PMID:
16996541
19.

Impaired muscle growth and response to insulin-like growth factor 1 in dysferlin-mediated muscular dystrophy.

Demonbreun AR, Fahrenbach JP, Deveaux K, Earley JU, Pytel P, McNally EM.

Hum Mol Genet. 2011 Feb 15;20(4):779-89. doi: 10.1093/hmg/ddq522. Epub 2010 Dec 1.

20.

Proteomic investigation of the molecular pathophysiology of dysferlinopathy.

De Palma S, Morandi L, Mariani E, Begum S, Cerretelli P, Wait R, Gelfi C.

Proteomics. 2006 Jan;6(1):379-85.

PMID:
16302276

Supplemental Content

Support Center